Skip to main content
CELLUMED CO., LTD. logo

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서” (Quarterly Report) and covers the period January 1 to March 31, 2026, with detailed financial and corporate information, tables of capital changes, share issues, corporate structure, and other substantive disclosures. It is a full interim/quarterly financial report, not merely an announcement or certification. Under the filing definitions, this is classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
[기재정정]금전대여결정
Regulatory Filings Classification · 78% confidence The document is a Korean stock exchange disclosure (“공시”) detailing a company decision to lend funds to a third party, including a correction to a prior disclosure. It does not contain comprehensive financial statements or an earnings summary, nor is it an AGM or management presentation. It is a general regulatory announcement of a corporate financing event (loan), fitting the fallback category for miscellaneous regulatory filings.
2026-05-15 Korean
소송등의제기ㆍ신청(일정금액이상의청구) (지급명령)
Legal Proceedings Report Classification · 95% confidence The document is a stock exchange disclosure detailing the initiation of legal proceedings (“소송등의 제기ㆍ신청”) by the company against another party, including case number, claim amount, court jurisdiction, and related details. This is not a financial report, earnings release, management change, or capital update, but specifically an update on a material lawsuit. Therefore, it best fits the Legal Proceedings Report category.
2026-05-15 Korean
[기재정정]금전대여결정
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a financial loan decision (금전대여결정) including loan amount, interest rate, collateral details, board resolution date, and related party information. It includes specific financial figures and terms of the loan, as well as explanations about the collateral and legal actions due to non-fulfillment of collateral provision. The document is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. It is a specific update on a capital/financing activity involving a loan decision. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 3323 characters, which is sufficient for a detailed financing update but not a full report. Hence, the classification is CAP with high confidence.
2026-04-30 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 88% confidence The document is a regulatory announcement concerning the setting and correction of the shareholder register closure period and record date for an extraordinary general meeting. It does not present financial results, management changes, dividend details, or capital transactions, nor is it a proxy statement or board composition update. It is a general regulatory disclosure that falls into the fallback category “Regulatory Filings (RNS).”
2026-04-24 Korean
[기재정정]주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 75% confidence The document is a regulatory announcement of the convocation and scheduling (with corrections) of an extraordinary shareholders’ meeting. It is not the full meeting materials (AGM materials), proxy statement, vote results, or a financial report. Therefore it falls under the general Regulatory Filings category (RNS).
2026-04-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.